The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes

Registros relacionados

• The final results of the interferon beta-1b 16-year long-term follow-up study
  por: Ebers, G, et al.
  Publicado em: (2006)
• Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
  por: Ebers, G, et al.
  Publicado em: (2009)
• Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
  por: Reder, A, et al.
  Publicado em: (2010)
• Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
  por: Goodin, D, et al.
  Publicado em: (2012)
• Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
  por: Goodin, D, et al.
  Publicado em: (2012)